Fig. 3: Number of sequelae due to SARS-CoV-2 infection for overall PASC and by organ system and relative percentage for overall PASC in the first, second and third year after SARS-CoV-2 infection by care setting of the acute phase compared to the control group without infection.
From: Three-year outcomes of post-acute sequelae of COVID-19
a, Number of post-acute sequelae overall and by organ system per 1,000 persons in the first, second and third year after SARS-CoV-2 infection by care setting of acute phase. b, Relative percentage of number of post-acute sequelae overall in the first, second and third year after SARS-CoV-2 infection by care setting of acute phase. Number of post-acute sequelae for COVID-19 not significantly different from the control group without infection in a year is marked by gray bars. The left column represents numbers of post-acute sequelae for the non-hospitalized COVID-19 group (n = 114,864), and the right column represents the numbers for the hospitalized COVID-19 group (n = 20,297), compared to the control group without infection (n = 5,206,835). Outcomes are ordered from top to bottom by cumulative number of post-acute sequelae at 3 years after infection.
